Iron oxide nanoparticles for biomedical applications: an updated patent review (2015–2021)

References

• Dulinska-Litewka J, Lazarczyk A, Halubiec P, et al. Superparamagnetic iron oxide nanoparticles-current and prospective medical applications. Materials (Basel). 2019;12(4):617.
   Web of Science ®Google Scholar
• Martinkova P, Brtnicky M, Kynicky J, et al. Iron oxide nanoparticles: innovative tool in cancer diagnosis and Therapy. Adv Healthc Mater. 2018;7(5):1700932.
   Web of Science ®Google Scholar
• Nabavinia M, Beltran-Huarac J. Recent progress in iron oxide nanoparticles as therapeutic magnetic agents for cancer treatment and tissue engineering. ACS Appl Bio Mater. 2020;3(12):8172–8187.
   PubMedGoogle Scholar
• Alphandery E. Iron oxide nanoparticles for therapeutic applications. Drug Discov Today. 2020;25(1):141–149.
   PubMed Web of Science ®Google Scholar
• Dadfar SM, Roemhild K, Drude NI, et al. Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019;138:302–325.
   PubMed Web of Science ®Google Scholar
• Ali A, Zafar H, Zia M, et al. Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl. 2016;9:49–67.
   PubMed Web of Science ®Google Scholar
• Yen SK, Padmanabhan P, Selvan ST. Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery. Theranostics. 2013;3(12):986–1003.
   PubMed Web of Science ®Google Scholar
• Alphandéry E. Iron oxide nanoparticles as multimodal imaging tools. RSC Adv. 2019;9(69):40577–40587.
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Sant S, Wang B, et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63(1–2):24–46.
   PubMed Web of Science ®Google Scholar
• Rosen JE, Chan L, Shieh DB, et al. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine. 2012;8(3):275–290.
   PubMed Web of Science ®Google Scholar
• Xie L, Jin W, Chen H, et al. Superparamagnetic iron oxide nanoparticles for cancer diagnosis and therapy. J Biomed Nanotechnol. 2019;15(2):215–416.
   PubMed Web of Science ®Google Scholar
• El-Hammadi MM, Arias JL. Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: a patent review (2008-present). Expert Opin Ther Pat. 2015;25(6):691–709.
   PubMed Web of Science ®Google Scholar
• Shen M, Hu Y, Li J, et al. inventor; Nat Univ Dong Hwa, assignee. Preparation method of RGD-modified subminiature superparamagnetic iron oxide nanoparticles. China patent CN104399092A. 2015 Mar 11.
   Google Scholar
• Shi X, Zhu J, Sun W, et al. inventor; Nat Univ Dong Hwa, Shanghai 10th Peoples Hospital, assignee. Preparation and application of iron oxide nanoparticle-loaded gamma-polyglutamic acid hydrogel. China patent CN104740656A. 2015 Jul 1.
   Google Scholar
• Shi X, Yu Z, Luo Y, et al. inventor; Nat Univ Dong Hwa, assignee. Preparation method of polyglutamic acid PGA-coated superparamagnetic iron oxide nanoparticle. China patent CN104548145A. 2015 Apr 29.
   Google Scholar
• Zhang Y, Jia Z, Xie J, et al. inventor; Univ Southeast, assignee. Preparation method and application of RGD-modified ultra-small magnetic iron oxide nanoparticles. China patent CN104258425A. 2015 Jan 7.
   Google Scholar
• Xiao W, Huang Q, Wen S, et al. inventor; Univ Zhejiang, assignee. Super-paramagnetic iron oxide nanoparticle compound as well as preparation method and application thereof. China patent CN105412951A. 2016 Mar 23.
   Google Scholar
• Gao J, Chen X, Zhao Z, inventor; US Health, Univ Xiamen, assignee. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging. United States patent US2016129138A1. 2016 May 12.
   Google Scholar
• Liu G, Zhang B, Liu L, et al. inventor; Univ Jilin, assignee. T1/T2 dual relaxation platinum-iron oxide-gold nanoparticle and preparation method. China patent CN107375952A. 2017 Nov 24.
   Google Scholar
• Torsten H, Matthew W, Donald WM, inventor; Univ Kent State Ohio, assignee. Aqueous synthesis of polyhedral “brick-like” iron oxide nanoparticles for hyperthermia and T2 MRI contrast enhancement, and for targeting endothelial cells for therapeutic delivery. United States patent US2018297857A1. 2018 Oct 18.
   Google Scholar
• Ling D, Li F, Liang Z, inventor; Univ Zhejiang, assignee. Preparation method of pH-responsive ultra-small iron oxide nanoparticle assembly, product thereof, and application of product. China patent CN108543082A. 2018 Sep 18.
   Google Scholar
• Yi P, Wang H, Yang X, inventor; Suzhou Inst Biomedical Eng & Tech Cas, assignee. Preparation method of iron oxide nanoparticle compound, compound and high-resolution cerebral blood volume MRI imaging method. China patent CN110665019A. 2020 Jan 10.
   Google Scholar
• Yi P, Wang H, Yang X, inventor; Suzhou Inst Biomedical Eng & Tech Cas, assignee. Preparation method of ultra-small-size iron oxide nanoparticles and application thereof. China patent CN110680931A. 2020 Jan 14.
   Google Scholar
• Rabanal H, Barahona F, inventor; Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), assignee. Iron oxide nanoparticles doped with cooper. Europe patent EP3646889A1. 2020 May 6.
   Google Scholar
• Artemovich AM, Georgievich MA, inventor; National Univ of Science and Tech Misis, assignee. Method of fabrication of preparation on the base of iron oxide magnetic nanoparticles for neoplasms diagnostics by magnetic resonance imaging. World patent WO2019093923A1. 2019 May 16.
   Google Scholar
• Zhou C, Sun T, Liu Y, et al. inventor; 2nd AF Hosp Army Medical Univ, Univ Southwest Petroleum, assignee. Fluorine-doped iron oxide nanoparticle contrast agent and preparation method thereof. China patent CN112656958A. 2021 Apr 16.
   Google Scholar
• Fan H, Miao Y, Zhang H, et al. inventor; Xian Supermag Nano Biotechnology Co., Ltd., assignee. Ultra-small iron oxide nanoparticle as well as preparation method and application thereof. China patent CN112299489A. 2021 Feb 2.
   Google Scholar
• Lee YS, Hyeon TH, Jeong JM, et al. inventor; Therabest Co., Ltd., assignee. Ultrafine iron oxide nanoparticle-based magnetic resonance imaging T1 contrast agent. Europe patent EP3922271A1. 2021 Dec 15.
   Google Scholar
• Pedro S, inventor; Uti LP, assignee. Methods and compositions for sustained immunotherapy. Canadian patent CA2929700A1. 2015 May 7.
   Google Scholar
• Mao H, Huang J, inventor; Univ Emory, assignee. Casein coated drug-loaded iron oxide nanoparticles. United States patent US2017333366A1. 2017 Nov 23.
   Google Scholar
• Kaittanis C, Grimm J, inventor; Memorial Sloan Kettering Cancer Center, assignee. Delivery of therapeutic compounds with iron oxide nanoparticles. United States patent US2019388542A1. 2019 Dec 26.
   Google Scholar
• Pedro S, inventor; Uti LP, assignee. Methods of treating autoimmune disease. World patent WO2019106435. 2019 Jun 6.
   Google Scholar
• Benjamin S, Mohammed S, Sanjay S, inventor; Lipid coated iron oxide nanoparticles for otitis media. World patent WO2021081251A1. 2021 Apr 29.
   Google Scholar
• Jesse J, Henry LW, George MR, et al. inventor; Riptide Bioscience Inc, assignee. Peptides having immunomodulatory properties. China patent CN113039194A. 2021 Jun 25.
   Google Scholar
• Lee D-Y, Jang S-B, Lee S-J, inventor; Univ Hanyang Ind Univ Coop Found, assignee. Glycyrrhizin-glycol chitosan conjugate-coated iron oxide nanoparticles and use thereof. China patent CN112367977A. 2021 Feb 12.
   Google Scholar
• Chen C-Y, Ali AA, Hsu F-T, et al. inventor; Sagabio Co., Ltd., assignee. Dextran-magnetic iron oxide nanoparticle, preparation and use in treating cancer and as contrast. World patent WO2018098705A1. 2018 Jun 7.
   Google Scholar
• Xiong F, Shan X, Gu N, et al. inventor; Zhenjiang First Peoples Hospital, assignee. Preparation method of novel iron-oxide nanoparticle and application of nanoparticle to tumor targeted diagnosis and treatment. China patent CN109125742A. 2019 Jan 4.
   Google Scholar
• Chen Y, Huang K, Zuo J, et al. inventor; Sun Yat Sen Memorial Hospital Sun Yat Sen Univ, Chen Y, Huang K, et al., assignee. Iron oxide nanoparticle compound and preparation method and application thereof. China patent CN110841072A. 2020 Feb 28.
   Google Scholar
• Bae ST, Jang JT, inventor; Neo Nanomedics Inc., assignee. Iron oxide nanoparticles doped with alkali metals or alkali earth metals capable of gigantic magnetic self-heating in biocompatible AC magnetic field and method of preparing the same. United States patent US2019023584A1. 2019 Jan 24.
   Google Scholar
• Ivkov R, inventor; Univ Johns Hopkins, assignee. Process for making iron oxide nanoparticle preparations for cancer hyperthermia. United States patent US2020155682A1. 2020 May 21.
   Google Scholar
• Shieh D-B, Tsai P-J, Lee W-T, inventor; Shieh DB, assignee. Use of iron oxide nanoparticle in inhibiting spore germination of clostridium difficile. China patent CN107041125A. 2017 Aug 11.
   Google Scholar
• Zhao Y, Zhu L, inventor ZYP, et al. assignee. Preparation method of copper-iron oxide and mixed nanoparticles and antibacterial application. China patent CN110074136A. 2019 Aug 2.
   Google Scholar
• Ling D, Yang Y, Chen Z, et al. inventor; Univ Zhejiang, assignee. Application of iron oxide nanoparticles in inhibiting monocyte activation. China patent CN109908171A. 2019 Jun 21.
   Google Scholar
• Xiong F, Sun Y, Zhang Y, et al. inventor; Univ Southeast, assignee. Application of poloxamer-modified iron oxide nanoparticles in preparation of medicines for treatment of non-alcoholic fatty liver disease. China patent CN109224083A. 2019 Jan 18.
   Google Scholar
• Daldrup-Link HE, inventor; Univ Leland Stanford Junior, assignee. Immuno-therapy for cancer treatment using iron oxide nanoparticles. United States patent US2017360965A1. 2017 Dec 21.
   Google Scholar
• Jeon BS, Kwon EB, Kim EG, et al. inventor; Hanwha Chemical Corp, assignee. Pharmaceutical composition for preventing or treating iron deficiency, comprising iron oxide nanoparticles. World patent WO2015102289A1. 2015 Jul 9.
   Google Scholar
• Chen C-L, Hsieh W-Y, Lin C-H, inventor; Ind Tech Res Inst, assignee. Method of treating iron deficiency. United States patent US2016008292A1. 2016 Jan 14.
   Google Scholar
• Sun J, Li N, Lu Q, et al. inventor; Univ Southeast, assignee. Application of superparamagnetic iron oxide nanoparticles in preparation of nerve magnetic stimulation enhancers for treating neurogenic diseases. China patent CN108853057A. 2018 Nov 23.
   Google Scholar
• Tang J, Zheng M, Yu F, et al. inventor; Second Xiangya Hospital of Central South University, assignee. Applications of iron oxide nanoparticles in preparation of drug for improving erlotinib resistance. China patent CN105055447A. 2015 Nov 18.
   Google Scholar
• Matthew FR, Praful KA, Jeffrey KS, et al. inventor; Lodespin Labs, Llc, assignee. The use of iron oxide nanoparticles in magnetically guided sentinel lymph node biopsy. World patent WO2016154552A1. 2016 Sep 29.
   Google Scholar
• Zhang B, Nie W, Su L, et al. inventor; Univ Guilin Technology, assignee. Preparation method for chondroitin sulfate modified iron-oxide nanoparticles capable of distributing in intercellular space of brains. China patent CN110201179A. 2019 Sep 6.
   Google Scholar
• Shen Y, Hu F, Huang Z, inventor; Shanghai East Hospital Tongji Univ Affiliated East Hospital, assignee. Anti-oxidative magnetic iron oxide nanoparticles and preparation method thereof. China patent CN109758581A. 2019 May 17.
   Google Scholar
• Caspani S, Magalhaes R, Araujo JP, et al. Magnetic nanomaterials as contrast agents for MRI. Materials (Basel). 2020;13(11): 2586.
   Web of Science ®Google Scholar
• Na HB, Song IC, Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater. 2009;21(21):2133–2148.
   Web of Science ®Google Scholar
• Avasthi A, Caro C, Pozo-Torres E, et al. Magnetic nanoparticles as MRI contrast agents. Top Curr Chem (Cham). 2020;378(3):40.
   PubMed Web of Science ®Google Scholar
• Neto DMA, da Costa LS, de Menezes FL, et al. A novel amino phosphonate-coated magnetic nanoparticle as MRI contrast agent. Appl Surf Sci. 2021;543:148824.
   Web of Science ®Google Scholar
• Zhao Z, Zhou Z, Bao J, et al. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging. Nat Commun. 2013;4(1):2266.
   PubMedGoogle Scholar
• Zhou Z, Yang L, Gao J, et al. Structure-relaxivity relationships of magnetic nanoparticles for magnetic resonance imaging. Adv Mater. 2019;31(8):e1804567.
   PubMed Web of Science ®Google Scholar
• Marcus M, Karni M, Baranes K, et al. Iron oxide nanoparticles for neuronal cell applications: uptake study and magnetic manipulations. J Nanobiotechnology. 2016;14(1):37.
   PubMedGoogle Scholar
• Uzhytchak M, Lynnyk A, Zablotskii V, et al. The use of pulsed magnetic fields to increase the uptake of iron oxide nanoparticles by living cells. Appl Phys Lett. 2017;111(24):243703.
   Web of Science ®Google Scholar
• Huang J, Shu Q, Wang L, et al. Layer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine. Biomaterials. 2015;39:105–113.
   PubMed Web of Science ®Google Scholar
• Zhang T, Xu Q, Huang T, et al. New insights into biocompatible iron oxide nanoparticles: a potential booster of gene delivery to stem cells. Small. 2020;16(37):e2001588.
   PubMed Web of Science ®Google Scholar
• Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy. Bioconjug Chem. 2011;22(10):1879–1903.
   PubMed Web of Science ®Google Scholar
• Xiong F, Hu K, Yu H, et al. A functional iron oxide nanoparticles modified with PLA-PEG-DG as tumor-targeted MRI contrast agent. Pharm Res. 2017;34(8):1683–1692.
   PubMed Web of Science ®Google Scholar
• Li J, Chen Y, Zeng L, et al. A nanoparticle carrier for co-delivery of gemcitabine and small interfering RNA in pancreatic cancer therapy. J Biomed Nanotechnol. 2016;12(8):1654–1666.
   PubMed Web of Science ®Google Scholar
• Das P, Colombo M, Prosperi D. Recent advances in magnetic fluid hyperthermia for cancer therapy. Colloids Surf B Biointerfaces. 2019;174:42–55.
   PubMed Web of Science ®Google Scholar
• Myrovali E, Maniotis N, Samaras T, et al. Spatial focusing of magnetic particle hyperthermia. Nanoscale Adv. 2020;2(1):408–416.
   PubMed Web of Science ®Google Scholar
• Lanier OL, Korotych OI, Monsalve AG, et al. Evaluation of magnetic nanoparticles for magnetic fluid hyperthermia. Int J Hyperthermia. 2019;36(1):687–701.
   PubMed Web of Science ®Google Scholar
• Slavin YN, Asnis J, Hafeli UO, et al. Metal nanoparticles: understanding the mechanisms behind antibacterial activity. J Nanobiotechnology. 2017;15(1):65.
   PubMedGoogle Scholar
• Stankic S, Suman S, Haque F, et al. Pure and multi metal oxide nanoparticles: synthesis, antibacterial and cytotoxic properties. J Nanobiotechnology. 2016;14(1):73.
   PubMedGoogle Scholar
• Alavi M, Rai M. Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria. Expert Rev Anti Infect Ther. 2019;17(6):419–428.
   PubMed Web of Science ®Google Scholar
• Morteza M, Ali SM, inventor; Morteza M, Ali SM. Pasteur inst of Iran, assignee. Super paramagnetic iron oxide nanoparticles with metallic coatings and a method of synthesizing the same. United States patent US2014234429A1. 2014 Aug 21.
   Google Scholar
• Munn LL. Cancer and inflammation. Wiley Interdiscip Rev Syst Biol Med. 2017;9(2):e1370.
   Web of Science ®Google Scholar
• Yang L, Xie X, Tu Z, et al. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther. 2021;6(1):255.
   PubMed Web of Science ®Google Scholar
• Grosse S, Stenvik J, Nilsen AM. Iron oxide nanoparticles modulate lipopolysaccharide-induced inflammatory responses in primary human monocytes. Int J Nanomedicine. 2016;11:4625–4642.
   PubMed Web of Science ®Google Scholar
• Wang XJ, Malhi H. Nonalcoholic fatty liver disease. Ann Intern Med. 2018;169(9):ITC65–80.
   PubMed Web of Science ®Google Scholar
• Cheung A, Figueredo C, Rinella ME. Nonalcoholic fatty liver disease: identification and management of high-risk patients. Am J Gastroenterol. 2019;114(4):579–590.
   PubMed Web of Science ®Google Scholar
• Sun Y, Shi F, Niu Y, et al. Fe3O4@OA@poloxamer nanoparticles lower triglyceride in hepatocytes through liposuction effect and nano-enzyme effect. Colloids Surf B Biointerfaces. 2019;184:110528.
   PubMed Web of Science ®Google Scholar
• Weber EW, Maus MV, Mackall CL. The emerging landscape of immune cell therapies. Cell. 2020;181(1):46–62.
   PubMed Web of Science ®Google Scholar
• Dougan M, Dranoff G. Immune therapy for cancer. Annu Rev Immunol. 2009;27(1):83–117.
   PubMedGoogle Scholar
• Soetaert F, Korangath P, Serantes D, et al. Cancer therapy with iron oxide nanoparticles: agents of thermal and immune therapies. Adv Drug Deliv Rev. 2020;163-164:65–83.
   PubMed Web of Science ®Google Scholar
• Zanganeh S, Hutter G, Spitler R, et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol. 2016;11(11):986–994.
   PubMed Web of Science ®Google Scholar
• Pasricha S-R, Tye-Din J, Muckenthaler MU, et al. Iron deficiency. Lancet. 2021;397(10270):233–248.
   PubMed Web of Science ®Google Scholar
• Camaschella C. New insights into iron deficiency and iron deficiency anemia. Blood Rev. 2017;31(4):225–233.
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Turnbull D, Sigurdsson E, et al. inventor; Univ New York,assignee. Detection of Alzheimer’s amyloid by magnetic resonance imaging. United States Patent US2003147811A1. 2003 Aug 7.
   Google Scholar
• Singh N, Jenkins GJ, Asadi R, et al. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1(1):5358.
   PubMedGoogle Scholar
• Qiu H, Wang P, Zhang M. A patent review of m-TOR inhibitors for cancer therapy (2011-2020). Expert Opin Ther Pat. 2021;31(11):965–975.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Davudian S, et al. The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull. 2017;7(3):339–348.
   PubMed Web of Science ®Google Scholar
• Wang P, Qiu H, He Y, et al. Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015-2019). Expert Opin Ther Pat. 2020;30(10):795–805.
   PubMed Web of Science ®Google Scholar
• Zhang M, Sai B, Cao P, et al. iron oxide nanoparticles synergize with erlotinib to suppress refractory non-small cell lung cancer cell proliferation through the inhibition of ErbB/PI3K/AKT and PTEN activation. J Biomed Nanotechnol. 2017;13(4):458–468.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Ohki A, Tanoue M, et al. Comparative study of extracellular and intracellular magnetic hyperthermia treatments using magnetic particle imaging. Open J Appl Sci. 2017;7(12):647–660.
   Google Scholar
• Pan J, Hu P, Guo Y, et al. Combined magnetic hyperthermia and immune therapy for primary and metastatic tumor treatments. ACS Nano. 2020;14(1):1033–1044.
   PubMed Web of Science ®Google Scholar
• Chen Z, Yin -J-J, Zhou Y-T, et al. Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ACS nano. 2012;6(5):4001–4012.
   PubMed Web of Science ®Google Scholar
• Escelsior A, Sterlini B, Murri MB, et al. Red-hot chili receptors: a systematic review of TRPV1 antagonism in animal models of psychiatric disorders and addiction. Behav Brain Res. 2020;393:112734.
   PubMed Web of Science ®Google Scholar
• Stanley SA, Sauer J, Kane RS, et al. Remote regulation of glucose homeostasis in mice using genetically encoded nanoparticles. Nat Med. 2015;21(1):92–98.
   PubMed Web of Science ®Google Scholar
• Zheng H, You J, Yao X, et al. Superparamagnetic iron oxide nanoparticles promote ferroptosis of ischemic cardiomyocytes. J Cell Mol Med. 2020;24(18):11030–11033.
   PubMed Web of Science ®Google Scholar
• Abo-zeid Y, Ismail NSM, McLean GR, et al. A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection. Eur J Pharm Sci. 2020;153:105465.
   PubMed Web of Science ®Google Scholar
• Dubreil C, Sainte CO, Lalatonne Y, et al. Tolerogenic iron oxide nanoparticles in type 1 diabetes: biodistribution and pharmacokinetics studies in nonobese diabetic mice. Small. 2018;14(40):e1802053.
   PubMed Web of Science ®Google Scholar